SK280815B6 - Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii - Google Patents

Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii Download PDF

Info

Publication number
SK280815B6
SK280815B6 SK1170-95A SK117095A SK280815B6 SK 280815 B6 SK280815 B6 SK 280815B6 SK 117095 A SK117095 A SK 117095A SK 280815 B6 SK280815 B6 SK 280815B6
Authority
SK
Slovakia
Prior art keywords
hydrogen
cells
thia
diazabicyclo
octane
Prior art date
Application number
SK1170-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK117095A3 (en
Inventor
Mi�E Kova�Evi�
Mira Grdi�A
Kre�Imir Paveli�
Marjeta Horvati�
Zora Mandi
Mirjana Tomi
Jure J. Herak
Irena Luki
Original Assignee
Pliva Farmaceutska, Kemijska, Prehrambena I Kozmeti�Ka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska, Kemijska, Prehrambena I Kozmeti�Ka filed Critical Pliva Farmaceutska, Kemijska, Prehrambena I Kozmeti�Ka
Publication of SK117095A3 publication Critical patent/SK117095A3/sk
Publication of SK280815B6 publication Critical patent/SK280815B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1170-95A 1994-09-21 1995-09-21 Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii SK280815B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR940577A HRP940577B1 (en) 1994-09-21 1994-09-21 Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy

Publications (2)

Publication Number Publication Date
SK117095A3 SK117095A3 (en) 1996-09-04
SK280815B6 true SK280815B6 (sk) 2000-08-14

Family

ID=10946157

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1170-95A SK280815B6 (sk) 1994-09-21 1995-09-21 Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii

Country Status (14)

Country Link
EP (1) EP0705606B1 (zh)
JP (1) JPH08310954A (zh)
CN (1) CN1127115A (zh)
AT (1) ATE164069T1 (zh)
BG (1) BG62237B1 (zh)
CA (1) CA2158678C (zh)
CZ (1) CZ285621B6 (zh)
DE (1) DE69501810T2 (zh)
ES (1) ES2115303T3 (zh)
HR (1) HRP940577B1 (zh)
HU (1) HU218287B (zh)
RU (1) RU2136284C1 (zh)
SI (1) SI9500297A (zh)
SK (1) SK280815B6 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598188A (en) * 1979-01-23 1980-07-25 Mitsui Toatsu Chem Inc Novel cephalosporin and its preparation
JPS57171994A (en) * 1981-04-15 1982-10-22 Asahi Chem Ind Co Ltd Novel compound
HRP921292A2 (en) 1992-11-17 1994-08-31 Pliva Pharm & Chem Works 5-thia-1,4-diazabicyclo (4.2.0.)octane -3,8-dioxo analogs of beta-lactams, the process for the preparation and use thereof

Also Published As

Publication number Publication date
SK117095A3 (en) 1996-09-04
EP0705606B1 (en) 1998-03-18
CA2158678A1 (en) 1996-03-22
CZ285621B6 (cs) 1999-10-13
CN1127115A (zh) 1996-07-24
CZ244795A3 (en) 1996-04-17
HU9502770D0 (en) 1995-11-28
DE69501810T2 (de) 1998-09-24
ATE164069T1 (de) 1998-04-15
BG100020A (bg) 1996-04-30
BG62237B1 (bg) 1999-06-30
ES2115303T3 (es) 1998-06-16
HRP940577A2 (en) 1997-04-30
HUT74422A (en) 1996-12-30
RU2136284C1 (ru) 1999-09-10
HU218287B (en) 2000-07-28
DE69501810D1 (de) 1998-04-23
EP0705606A1 (en) 1996-04-10
SI9500297A (en) 1996-04-30
CA2158678C (en) 2000-04-18
HRP940577B1 (en) 1998-12-31
JPH08310954A (ja) 1996-11-26

Similar Documents

Publication Publication Date Title
BR0009083A (pt) Derivado de amida, processo para a preparação de um derivado de amida, composição farmacêutica, uso de um derivado de amida, método de tratamento de doenças ou de condições médicas mediadas por citocinas
BR0212346A (pt) Composto ou um sal farmaceuticamente aceitável, solvato, solvato deste sal ou uma pró-droga do mesmo, processo para a preparação do mesmo, uso deste, método para produzir um efeito inibidor de ibat em um animal de sangue quente, como um humano, em necessidade deste tratamento, e, composição farmacêutica
SK281214B6 (sk) Perorálny kvapalný farmaceutický prostriedok, spôsob jeho výroby a jeho použitie
ES2130247T3 (es) Derivados amidino y su uso como inhibidores de la oxido nitrico sintasa.
KR19980703830A (ko) 바이러스 및 암 성장 억제용, 엔-포스포노글리신 유도체 함유 약학 조성물
JPH09501653A (ja) 薬学的組成物
SK284332B6 (sk) Lokálne anestetikum na vonkajšie použitie
US3991190A (en) Treatment of viral infections
ATE201671T1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
DE3061693D1 (en) Secondary amines, their preparation and use in pharmaceutical compositions
FI834800A0 (fi) Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat
SK280815B6 (sk) Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii
DE3855824T2 (de) Anti-Plasmin Depressant
KR100718030B1 (ko) 변형성 관절증 치료제
ITMI921855A1 (it) Derivati di catecolammine, processo per la loro preparazione e composizioni farmaceutiche che li contengono
HRP940433A2 (en) Use of 4-oxo-azetidin-2-sulfinic and 2-sulfonic acids and derivatives thereof in antitumor therapy
NL8600480A (nl) Gestabiliseerde injectiesamenstellingen en de bereiding ervan.
JPH02240072A (ja) フエニルピラジンの塩、その製法及び該塩を含有する中枢神経系作用剤並びに該医薬の製法
JPH04128220A (ja) 抗ヘルペスウイルス剤
ITMI951252A1 (it) Bicarbonati di derivati della 2,6-dimetilanilina loro uso in terapia e composizioni farmaceutiche che li comprendono
RU94035756A (ru) Производные имидазола, являющиеся ингибиторами питокинов, способы их получения, фармацевтическая композиция
DE2064113B2 (de) N.N*-Diacy !hydrazinderivate, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel